Intervention Review

Sulpiride for schizophrenia

  1. Bernardo GO Soares1,*,
  2. Mark Fenton2,
  3. Pierre Chue3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 25 JAN 1999

Assessed as up-to-date: 24 NOV 1998

DOI: 10.1002/14651858.CD001162


How to Cite

Soares BGO, Fenton M, Chue P. Sulpiride for schizophrenia. Cochrane Database of Systematic Reviews 1999, Issue 1. Art. No.: CD001162. DOI: 10.1002/14651858.CD001162.

Author Information

  1. 1

    Universidade Federal de São Paulo, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  2. 2

    National Institute for Health and Clinical Excellence, Database of Uncertainties about the Effects of Treatments (DUETs), Manchester, UK

  3. 3

    University of Alberta, Department of Psychiatry, Edmonton, Alberta, Canada

*Bernardo GO Soares, Brazilian Cochrane Centre, Universidade Federal de São Paulo, Rua Pedro de Toledo 598, São Paulo, São Paulo, 04039-001, Brazil. bgosoares@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 25 JAN 1999

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.